May 30, 2024- Henry Schein Medical announced that it has partnered with the United Football League (UFL) as the 2024 official medical product sponsor. Throughout the 2024 season, the Company is supplying UFL athletic trainers with products, equipment, and supplies to help keep athletes at the top of their game. From automated external defibrillators and first aid kits to … [Read more...]
Baxter’s HDx Therapy associated with 25% lower mortality rate for up to four years
May 30, 2024- Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, “Survival of expanded hemodialysis and high-flux … [Read more...]
Owens & Minor presents at The Leerink Partners’ Healthcare Crossroads Conference
May 30, 2024- Owens & Minor, Inc.'s Ed Pesicka, the Company’s President and Chief Executive Officer and Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer, participated in a webcasted fireside chat on Wednesday, May 29, 2024 at Leerink Partners’ Healthcare Crossroads Conference in Austin, Texas. Owens & Minor is also hosting one-on-one … [Read more...]
HealthTrust Advisory Summit explores top issues facing hospital operators
May 30, 2024- HealthTrust Performance Group recently hosted executives from leading health systems at a summit focused on important issues for hospital leaders. The event was held in Phoenix, Arizona and provided leaders with insight on key topics in healthcare, notably: the role of AI in care transformation, cybersecurity and defensing against ransomware attacks, the current … [Read more...]
AHA study finds heart healthy behaviors may help reverse rapid cell aging
May 29, 2024- The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research by the American Heart Association. The study analyzed whether a chemical modification process known as DNA methylation, which regulates gene expression, may be one … [Read more...]
Vizient publishes latest Diagnostic Imaging Tech Watch
May 29, 2024- Vizient has released the “2024 Diagnostic Imaging Top Trends” report, highlighting national trends in imaging exams. The article forecasts standard outpatient imaging to grow 11% in the next decade and advanced imaging 13%, led by CT and PET exams, according to Vizient. The report also provides insights and perspective for health system to navigate the changes in … [Read more...]
Skin cancer awareness
May 29, 2024- Skin Cancer Awareness Month is recognized annually in May to highlight disease risk factors and prevention strategies. The incidence of skin cancer is increasing, with 1 in 5 Americans developing skin cancer by the age of 70, according to The Skin Cancer Foundation. Skin cancer is a disease associated with the abnormal growth of skin cells, noted the Mayo Clinic, … [Read more...]
Pfizer helps to address antimicrobial resistance internationally
May 29, 2024- Antimicrobial resistance (AMR) is one of the biggest threats to global health and is estimated to be responsible for 1.27 million deaths per year. In 2019, an estimated 60,000 people died from sepsis in Malawi, of which approximately 19,000 deaths were the result of bacterial AMR. Pfizer, The Malawi Ministry of Health, bioMérieux, and announced a … [Read more...]
Thermo Fisher Scientific releases 2023 Corporate Social Responsibility report
May 29, 2024- Thermo Fisher Scientific Inc. released its 2023 Corporate Social Responsibility (CSR) report, which provides an overview of the company, its CSR priorities and the progress enabled by its more than 120,000 colleagues. In reporting its CSR progress, the company considers internationally recognized standards, guidelines and reference frameworks, including the Global … [Read more...]
Addressing supply disruptions
May 28, 2024- The U.S. Food and Drug Administration (FDA) announced in early March that it is requesting $7.2 billion as part of the President’s fiscal year (FY) 2025 proposed budget. Approximately $12.3 million of the funding will go directly toward addressing supply-chain disruptions, supporting supply chain resiliency, and advancing medical product safety, according to the … [Read more...]